FMR LLC – Alnylam Pharmaceuticals, Inc. Transaction History
FMR LLC portfolio value:
$2.59B
portfolio value
FMR LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -9.60% | -1.37M shares | 502.75M | $200.16 | 12.94M |
| Q2 2022 | share | Decrease | -10.72% | -1.72M shares | -530.77M | $145.85 | 14.32M |
| Q1 2022 | share | Decrease | -10.56% | -1.89M shares | -422.22M | $163.29 | 16.04M |
| Q4 2021 | share | Increase | +0.63% | 113.09K shares | -323.63M | $171.03 | 17.94M |
| Q3 2021 | share | Increase | +1.11% | 195.2K shares | 376.97M | $188.81 | 17.82M |
| Q2 2021 | share | Increase | +0.47% | 81.82K shares | 511.06M | $169.52 | 17.63M |
| Q1 2021 | share | Increase | +9.06% | 1.45M shares | 386.4M | $141.19 | 17.54M |
| Q4 2020 | share | Decrease | -2.29% | -376.98K shares | -306.40M | $129.97 | 16.09M |
| Q3 2020 | share | Decrease | -3.55% | -605.70K shares | -131.04M | $145.6 | 16.46M |
| Q2 2020 | share | Increase | +1.60% | 269.32K shares | 699.66M | $148.11 | 17.07M |
| Q1 2020 | share | Increase | +0.51% | 84.93K shares | -96.42M | $108.85 | 16.80M |
| Q4 2019 | share | Increase | +0.24% | 39.22K shares | 584.18M | $115.17 | 16.72M |
| Q3 2019 | share | Increase | +4.38% | 700.63K shares | 181.95M | $80.42 | 16.68M |
| Q2 2019 | share | Increase | +0.22% | 34.85K shares | -330.57M | $72.56 | 15.98M |
| Q1 2019 | share | Increase | +5.22% | 791.11K shares | 385.20M | $93.45 | 15.94M |
| Q4 2018 | share | Increase | +0.36% | 54.63K shares | -216.62M | $72.91 | 15.15M |
| Q3 2018 | share | Increase | +0.14% | 21.55K shares | -163.52M | $87.52 | 15.09M |
| Q2 2018 | share | Increase | +0.35% | 52.65K shares | -304.49M | $98.49 | 15.07M |
| Q1 2018 | share | Increase | +1.01% | 150.08K shares | -100.38M | $119.1 | 15.02M |
| Q4 2017 | share | Increase | +8.11% | 1.11M shares | 273.28M | $127.05 | 14.87M |
| Q3 2017 | share | Increase | +0.27% | 36.85K shares | 522.10M | $117.49 | 13.76M |
| Q2 2017 | share | Increase | +6.32% | 815.27K shares | 433.02M | $79.76 | 13.72M |
| Q1 2017 | share | Increase | +0.28% | 35.80K shares | 179.59M | $51.25 | 12.90M |
| Q4 2016 | share | Increase | +0.10% | 13.38K shares | -389.63M | $37.44 | 12.87M |
| Q3 2016 | share | Increase | +0.19% | 24.61K shares | 159.39M | $67.78 | 12.85M |
| Q2 2016 | share | Increase | +0.24% | 30.78K shares | -91.49M | $55.49 | 12.83M |
| Q1 2016 | share | Increase | +0.73% | 92.93K shares | -392.89M | $62.77 | 12.80M |